NYSE:BHC - Bausch Health Companies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $31.50
  • Forecasted Upside: -4.46 %
  • Number of Analysts: 12
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$32.97
▲ +1.07 (3.35%)
1 month | 3 months | 12 months
Get New Bausch Health Companies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BHC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$31.50
▼ -4.46% Downside Potential
This price target is based on 12 analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is $31.50, with a high forecast of $50.00 and a low forecast of $17.00. The average price target represents a -4.46% upside from the last price of $32.97.
Buy
The current consensus among 12 contributing investment analysts is to buy stock in Bausch Health Companies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 11 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/14/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/13/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/12/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/10/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 6 hold ratings
  • 0 sell ratings
9/8/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/7/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings
2/5/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
3/7/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/4/2021Morgan StanleyBoost Price TargetEqual Weight$22.00 ➝ $35.00N/A
i
3/2/2021CitigroupBoost Price Target$32.00 ➝ $37.00Low
i
2/26/2021Morgan StanleyBoost Price TargetEqual Weight$22.00 ➝ $35.00Medium
i
2/25/2021BarclaysBoost Price TargetOverweight$27.00 ➝ $35.00Low
i
2/17/2021Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$26.00 ➝ $42.00Low
i
2/16/2021JPMorgan Chase & Co.Boost Price TargetOverweight$32.00 ➝ $38.00Low
i
1/22/2021Piper SandlerDowngradeOverweight ➝ Neutral$25.00 ➝ $30.00Low
i
1/15/2021Jefferies Financial GroupBoost Price Target$27.00 ➝ $33.00Low
i
11/5/2020Piper SandlerLower Price TargetOverweight$26.00 ➝ $25.00Low
i
10/28/2020Wells Fargo & CompanyLower Price TargetEqual Weight$18.00 ➝ $17.00Medium
i
10/26/2020BarclaysBoost Price TargetOverweight$28.00 ➝ $29.00High
i
9/17/2020Bank of AmericaUpgradeUnderperform ➝ Neutral$19.00High
i
8/24/2020HC WainwrightReiterated RatingBuy$64.00 ➝ $50.00High
i
Rating by Ram Selvaraju at HC Wainwright
8/19/2020Piper SandlerLower Price TargetOverweight$32.00 ➝ $26.00High
i
8/10/2020Royal Bank of CanadaBoost Price TargetSector Perform$23.00 ➝ $26.00Low
i
8/10/2020CitigroupLower Price TargetBuy$27.00 ➝ $26.00Medium
i
8/7/2020BarclaysBoost Price TargetOverweight$25.00 ➝ $28.00High
i
7/31/2020Royal Bank of CanadaLower Price TargetSector Perform$24.00 ➝ $23.00Low
i
7/7/2020Bank of AmericaBoost Price TargetUnderperform$12.00 ➝ $14.00High
i
6/17/2020HC WainwrightBoost Price TargetBuy$50.00 ➝ $64.00Medium
i
Rating by Ram Selvaraju at HC Wainwright
5/8/2020CfraLower Price TargetHold$28.00 ➝ $18.00Low
i
5/8/2020SunTrust BanksLower Price TargetBuy$25.00 ➝ $24.00High
i
5/8/2020Royal Bank of CanadaLower Price TargetSector Perform$25.00 ➝ $24.00High
i
4/30/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$17.00 ➝ $18.00Low
i
Rating by David Maris at Wells Fargo & Company
4/28/2020HC WainwrightReiterated RatingBuy$50.00Medium
i
Rating by Ram Selvaraju at HC Wainwright
4/28/2020Royal Bank of CanadaLower Price TargetSector Perform$26.00 ➝ $25.00High
i
4/24/2020CitigroupInitiated CoverageBuy$30.00High
i
4/23/2020Jefferies Financial GroupLower Price TargetBuy$35.00 ➝ $27.00Medium
i
4/2/2020Morgan StanleyDowngradeOverweight ➝ Equal WeightLow
i
3/23/2020HC WainwrightLower Price TargetBuy$60.00 ➝ $50.00High
i
Rating by Ram Selvaraju at HC Wainwright
3/23/2020Wells Fargo & CompanyLower Price TargetEqual Weight$32.00 ➝ $17.00High
i
Rating by David Maris at Wells Fargo & Company
3/17/2020Royal Bank of CanadaLower Price TargetSector Perform$31.00 ➝ $26.00Medium
i
2/20/2020Royal Bank of CanadaLower Price TargetSector Perform$33.00 ➝ $31.00High
i
2/20/2020SunTrust BanksLower Price TargetBuy$32.00 ➝ $31.00Low
i
2/19/2020CowenReiterated RatingBuy$40.00Low
i
Rating by Ken Cacciatore at Cowen Inc
2/19/2020GuggenheimReiterated RatingBuy$36.00Low
i
Rating by Dana Flanders at Guggenheim
2/11/2020Morgan StanleyLower Price TargetOverweight$34.00 ➝ $32.00Low
i
2/4/2020Royal Bank of CanadaBoost Price TargetSector Perform$31.00 ➝ $33.00High
i
1/29/2020Wolfe ResearchDowngradeOutperform ➝ Peer PerformLow
i
1/26/2020BarclaysReiterated RatingBuy$33.00Low
i
1/22/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$32.00Medium
i
Rating by David Maris at Wells Fargo & Company
12/30/2019Piper Jaffray CompaniesBoost Price TargetNeutral ➝ Overweight$30.00 ➝ $39.00Medium
i
12/23/2019HC WainwrightReiterated RatingBuy$60.00N/A
i
Rating by Ram Selvaraju at HC Wainwright
12/12/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$32.00 ➝ $38.00High
i
12/2/2019HC WainwrightReiterated RatingBuy$54.00 ➝ $60.00Low
i
12/2/2019The Goldman Sachs GroupInitiated CoverageNeutral$30.00Low
i
11/5/2019BarclaysBoost Price TargetOverweight$28.00 ➝ $30.00Low
i
Rating by Balaji Prasad at Barclays PLC
10/25/2019CowenInitiated CoverageOutperform$35.00Medium
i
9/17/2019Wells Fargo & CompanyReiterated RatingSellLow
i
Rating by David Maris at Wells Fargo & Company
9/12/2019GuggenheimInitiated CoverageBuy$30.00High
i
8/15/2019TD SecuritiesUpgradeHold ➝ Buy$28.00Medium
i
8/7/2019HC WainwrightBoost Price TargetMarket Perform ➝ Buy$50.00 ➝ $54.00Low
i
7/29/2019HC WainwrightLower Price TargetBuy$58.00 ➝ $50.00Low
i
7/19/2019Wolfe ResearchInitiated CoverageOutperform ➝ Outperform$31.00Low
i
7/15/2019Wells Fargo & CompanyReiterated RatingSellLow
i
Rating by David Maris at Wells Fargo & Company
7/8/2019BarclaysSet Price TargetBuy$28.00Low
i
Rating by Balaji Prasad at Barclays PLC
6/20/2019MizuhoSet Price TargetBuy$45.00Medium
i
Rating by Irina Rivkind Koffler at Mizuho
6/11/2019Piper Jaffray CompaniesSet Price TargetBuy$29.00Medium
i
Rating by David Amsellem at Piper Jaffray Companies
6/11/2019BarclaysReiterated RatingOverweight ➝ Overweight$28.00Medium
i
5/31/2019Cantor FitzgeraldSet Price TargetBuy$32.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
5/17/2019Wells Fargo & CompanySet Price TargetSell$9.00Low
i
Rating by David Maris at Wells Fargo & Company
5/13/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$24.80Low
i
5/7/2019MizuhoBoost Price TargetBuy$41.00 ➝ $45.00Low
i
4/25/2019Cantor FitzgeraldReiterated RatingBuy$32.00Low
i
4/2/2019Piper Jaffray CompaniesSet Price TargetBuy$28.00Low
i
Rating by David Amsellem at Piper Jaffray Companies
3/20/2019Bank of AmericaReiterated RatingUnderperform$18.00High
i
3/19/2019SunTrust BanksInitiated CoverageBuy ➝ Buy$30.00High
i
3/18/2019MizuhoBoost Price TargetBuy$39.00 ➝ $41.00High
i
2/28/2019HC WainwrightReiterated RatingBuyMedium
i
Rating by Ram Selvaraju at HC Wainwright
2/19/2019Wells Fargo & CompanyBoost Price TargetSell ➝ Underperform$9.00 ➝ $25.19High
i
Rating by David Maris at Wells Fargo & Company
1/6/2019MizuhoReiterated RatingBuy$39.00High
i
1/2/2019UBS GroupUpgradeBuyHigh
i
1/1/2019Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$27.00High
i
Rating by David Amsellem at Piper Jaffray Companies
12/17/2018Morgan StanleySet Price TargetBuy$32.00High
i
Rating by David Risinger at Morgan Stanley
12/14/2018HC WainwrightUpgradeAverage ➝ BuyLow
i
12/12/2018Wells Fargo & CompanySet Price TargetSell$9.00Medium
i
Rating by David Maris at Wells Fargo & Company
11/30/2018MizuhoBoost Price TargetBuy ➝ Buy$35.00 ➝ $38.00Low
i
11/13/2018BMO Capital MarketsReiterated RatingHold$26.00Medium
i
11/7/2018TD SecuritiesBoost Price TargetHold$24.00 ➝ $28.00Low
i
11/7/2018Royal Bank of CanadaBoost Price TargetHold$30.00 ➝ $31.00Medium
i
Rating by Douglas Miehm at Royal Bank of Canada
11/6/2018Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Louise Chen at Cantor Fitzgerald
11/5/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$32.00High
i
Rating by David Risinger at Morgan Stanley
10/15/2018HC WainwrightSet Price TargetHold$25.00Low
i
Rating by Ram Selvaraju at HC Wainwright
10/8/2018HC WainwrightSet Price TargetHold$25.00Medium
i
Rating by Ram Selvaraju at HC Wainwright
10/8/2018MizuhoReiterated RatingBuy$35.00Medium
i
10/8/2018Royal Bank of CanadaSet Price TargetSector Perform ➝ Hold$26.00 ➝ $30.00Medium
i
Rating by Douglas Miehm at Royal Bank of Canada
9/13/2018HC WainwrightReiterated RatingHold$25.00High
i
Rating by Ram Selvaraju at HC Wainwright
9/13/2018Piper Jaffray CompaniesUpgradeUnderweight ➝ Neutral$16.00 ➝ $19.00High
i
Rating by David Amsellem at Piper Jaffray Companies
9/12/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$30.00High
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
9/12/2018Cantor FitzgeraldReiterated RatingBuy$32.00High
i
Rating by L. Chen at Cantor Fitzgerald
8/31/2018HC WainwrightReiterated RatingHold$20.00Medium
i
8/13/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$20.00 ➝ $22.00Medium
i
8/8/2018Royal Bank of CanadaBoost Price TargetHold$25.00 ➝ $26.00Low
i
Rating by Douglas Miehm at Royal Bank of Canada
8/8/2018JPMorgan Chase & Co.Boost Price TargetUnderweight$18.00Low
i
8/7/2018Piper Jaffray CompaniesSet Price TargetSell$16.00Low
i
Rating by David Amsellem at Piper Jaffray Companies
8/7/2018Cantor FitzgeraldReiterated RatingBuy$32.00Low
i
Rating by L. Chen at Cantor Fitzgerald
8/7/2018MizuhoReiterated RatingBuy$31.00High
i
8/6/2018Wells Fargo & CompanyReiterated RatingSellHigh
i
Rating by David Maris at Wells Fargo & Company
7/23/2018Piper Jaffray CompaniesSet Price TargetSell$13.00Low
i
Rating by David Amsellem at Piper Jaffray Companies
6/29/2018Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
6/29/2018MizuhoReiterated RatingBuy$31.00Medium
i
6/22/2018TD SecuritiesDowngradeBuy ➝ Hold$24.00Low
i
Rating by Lennox Gibbs at TD Securities
6/20/2018HC WainwrightReiterated RatingHold$20.00Low
i
Rating by Ram Selvaraju at HC Wainwright
6/6/2018BarclaysUpgradeEqual Weight ➝ Overweight$20.00 ➝ $34.00High
i
6/5/2018HC WainwrightSet Price TargetHold$20.00High
i
Rating by Ram Selvaraju at HC Wainwright
6/1/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$25.00Low
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
5/15/2018MizuhoUpgradeNeutral ➝ BuyLow
i
5/14/2018Cantor FitzgeraldSet Price TargetBuy$25.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
5/11/2018BMO Capital MarketsBoost Price TargetMarket Perform$17.00 ➝ $20.00Low
i
5/9/2018BTIG ResearchReiterated RatingHoldLow
i
Rating by Tim Chiang at BTIG Research
5/9/2018Jefferies Financial GroupBoost Price TargetBuy$23.00Low
i
5/9/2018TD SecuritiesBoost Price TargetBuy$23.00 ➝ $24.00Low
i
Rating by Lennox Gibbs at TD Securities
5/9/2018Royal Bank of CanadaBoost Price TargetSector Perform$18.00 ➝ $19.00Low
i
Rating by Douglas Miehm at Royal Bank of Canada
5/9/2018JPMorgan Chase & Co.Set Price TargetSell$13.00High
i
Rating by Chris Schott at JPMorgan Chase & Co.
5/9/2018Piper Jaffray CompaniesSet Price TargetSell$13.00Low
i
Rating by David Amsellem at Piper Jaffray Companies
5/8/2018The Goldman Sachs GroupSet Price TargetSell$16.00Medium
i
Rating by Dana Flanders at The Goldman Sachs Group, Inc.
5/8/2018Cantor FitzgeraldSet Price TargetBuy$25.00High
i
Rating by Louise Chen at Cantor Fitzgerald
5/7/2018HC WainwrightReiterated RatingPositive ➝ Hold$16.00Medium
i
Rating by Ram Selvaraju at HC Wainwright
5/2/2018Royal Bank of CanadaSet Price TargetHold$18.00Medium
i
Rating by Douglas Miehm at Royal Bank of Canada
4/30/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy$20.00 ➝ $22.00Low
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
4/6/2018MizuhoUpgradeUnderperform ➝ Neutral$10.00 ➝ $15.00High
i
3/21/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$20.00Medium
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
3/20/2018Wells Fargo & CompanyReiterated RatingSellMedium
i
Rating by David Maris at Wells Fargo & Company
3/15/2018HC WainwrightReiterated RatingHold$16.00Medium
i
Rating by Ram Selvaraju at HC Wainwright
3/12/2018Wells Fargo & CompanyReiterated RatingSellLow
i
Rating by David Maris at Wells Fargo & Company
3/5/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$18.00Low
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
3/1/2018TD SecuritiesLower Price TargetBuy$27.00 ➝ $23.00Low
i
Rating by Lennox Gibbs at TD Securities
3/1/2018Piper Jaffray CompaniesReiterated RatingSell$12.00 ➝ $10.00High
i
Rating by David Amsellem at Piper Jaffray Companies
2/28/2018CfraDowngradeHoldHigh
i
Rating by Jeffrey Loo at Cfra
2/28/2018Cantor FitzgeraldSet Price TargetBuy$25.00Medium
i
Rating by Louise Chen at Cantor Fitzgerald
2/28/2018Wells Fargo & CompanyReiterated RatingSellMedium
i
Rating by David Maris at Wells Fargo & Company
2/26/2018HC WainwrightReiterated RatingNeutral$18.00Low
i
Rating by Ram Selvaraju at HC Wainwright
2/21/2018Deutsche Bank AktiengesellschaftSet Price TargetHold$20.00Low
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
1/24/2018The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$18.00High
i
1/19/2018Cantor FitzgeraldSet Price TargetBuy$25.00Medium
i
Rating by Louise Chen at Cantor Fitzgerald
1/16/2018Wells Fargo & CompanyReiterated RatingSell$9.00Low
i
Rating by David Maris at Wells Fargo & Company
1/16/2018HC WainwrightBoost Price TargetBuy$17.00 ➝ $24.00High
i
Rating by Ram Selvaraju at HC Wainwright
1/16/2018HC WainwrightSet Price TargetHold$17.00 ➝ $24.00High
i
Rating by Ram Selvaraju at HC Wainwright
1/5/2018TD SecuritiesBoost Price TargetBuy$20.00 ➝ $27.00High
i
1/4/2018Wells Fargo & CompanyReiterated RatingSellLow
i
Rating by David Maris at Wells Fargo & Company
1/1/2018Cantor FitzgeraldSet Price TargetBuy$25.00High
i
Rating by Louise Chen at Cantor Fitzgerald
12/26/2017Cantor FitzgeraldSet Price TargetBuy$25.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
12/15/2017MizuhoBoost Price TargetUnderperform ➝ Underperform$7.00 ➝ $10.00Medium
i
12/14/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$12.00High
i
Rating by Chris Schott at JPMorgan Chase & Co.
12/3/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$18.00Low
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/16/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$19.00 ➝ $18.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/13/2017Wells Fargo & CompanyReiterated RatingSellN/A
i
Rating by David Maris at Wells Fargo & Company
11/13/2017BMO Capital MarketsBoost Price TargetMarket Perform$16.00 ➝ $17.00N/A
i
11/10/2017Piper Jaffray CompaniesReiterated RatingSell$12.00N/A
i
Rating by David Amsellem at Piper Jaffray Companies
11/9/2017HC WainwrightReiterated RatingHold$17.00N/A
i
Rating by Ram Selvaraju at HC Wainwright
11/8/2017Royal Bank of CanadaSet Price TargetSector Perform$18.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
11/8/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$19.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/7/2017TD SecuritiesUpgradeHold ➝ Buy$20.00N/A
i
11/3/2017TD SecuritiesUpgradeHold ➝ Buy$20.00N/A
i
11/3/2017HC WainwrightReiterated RatingHold$17.00N/A
i
Rating by Ram Selvaraju at HC Wainwright
10/31/2017Cantor FitzgeraldSet Price TargetBuy$23.00N/A
i
Rating by Louise Chen at Cantor Fitzgerald
10/30/2017BMO Capital MarketsReiterated RatingHold$16.00N/A
i
10/27/2017Wells Fargo & CompanyReiterated RatingSellN/A
i
Rating by David Maris at Wells Fargo & Company
10/22/2017Piper Jaffray CompaniesSet Price TargetSell$14.00N/A
i
Rating by David Amsellem at Piper Jaffray Companies
10/20/2017Royal Bank of CanadaLower Price TargetSector Perform$21.00 ➝ $18.00N/A
i
Rating by Joel Hurren at Royal Bank of Canada
10/9/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$18.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
10/4/2017HC WainwrightReiterated RatingHold$17.00Low
i
Rating by Ram Selvaraju at HC Wainwright
10/3/2017Canaccord GenuityReiterated RatingHold$16.00Low
i
Rating by Neil Maruoka at Canaccord Genuity
9/30/2017Wells Fargo & CompanyReiterated RatingUnderperform$8.00High
i
Rating by David Maris at Wells Fargo & Company
9/28/2017Cantor FitzgeraldReiterated RatingBuy$23.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
9/25/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$19.00Low
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
9/18/2017HC WainwrightReiterated RatingHold$17.00Low
i
Rating by Ram Selvaraju at HC Wainwright
9/17/2017Piper Jaffray CompaniesReiterated RatingSell$14.00Low
i
Rating by David Amsellem at Piper Jaffray Companies
8/29/2017Cantor FitzgeraldReiterated RatingBuy$23.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
8/29/2017MizuhoReiterated RatingSell$8.00 ➝ $7.00High
i
8/21/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$19.00High
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
8/21/2017Stifel NicolausReiterated RatingBuy$45.00Medium
i
8/21/2017HC WainwrightSet Price TargetHold$17.00Low
i
Rating by Ram Selvaraju at HC Wainwright
8/16/2017Cantor FitzgeraldSet Price TargetBuy$23.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
8/10/2017BMO Capital MarketsReiterated RatingMarket Perform$16.00Low
i
8/10/2017Rodman & RenshawReiterated RatingNeutral$17.00High
i
8/10/2017Jefferies Financial GroupReiterated RatingBuy$18.00High
i
Rating by David Steinberg at Jefferies Financial Group Inc.
8/10/2017Stifel NicolausReiterated RatingBuy$35.00Medium
i
8/10/2017Wells Fargo & CompanyReiterated RatingUnderperform$9.00Medium
i
Rating by David Maris at Wells Fargo & Company
8/10/2017Canaccord GenuitySet Price TargetHold$14.00Medium
i
Rating by Neil Maruoka at Canaccord Genuity
8/9/2017MizuhoReiterated RatingUnderperform$8.00Medium
i
8/9/2017ScotiabankBoost Price TargetSector Perform$14.00 ➝ $16.00Medium
i
8/9/2017HC WainwrightSet Price TargetHold$17.00High
i
Rating by Ram Selvaraju at HC Wainwright
8/9/2017Piper Jaffray CompaniesSet Price TargetSell$14.00High
i
Rating by David Amsellem at Piper Jaffray Companies
8/4/2017Canaccord GenuitySet Price TargetHold$14.00Low
i
Rating by Neil Maruoka at Canaccord Genuity
8/3/2017Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$19.00 ➝ $21.00High
i
Rating by Douglas Miehm at Royal Bank of Canada
7/30/2017Wells Fargo & CompanyDropped CoverageSell$9.00High
i
Rating by David Maris at Wells Fargo & Company
7/28/2017Cantor FitzgeraldSet Price TargetBuy$23.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
7/27/2017BMO Capital MarketsReiterated RatingHold$15.00High
i
7/17/2017JPMorgan Chase & Co.Set Price TargetHold$10.00Low
i
Rating by Chris Schott at JPMorgan Chase & Co.
7/17/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$18.00 ➝ $19.00High
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
7/17/2017Stifel NicolausReiterated RatingBuy$35.00Low
i
7/14/2017Jefferies Financial GroupReiterated RatingBuy$18.00Low
i
Rating by David Steinberg at Jefferies Financial Group Inc.
7/14/2017Wells Fargo & CompanyReiterated RatingSellLow
i
Rating by David Maris at Wells Fargo & Company
7/14/2017Piper Jaffray CompaniesReiterated RatingUnderweight$10.00High
i
7/12/2017TD SecuritiesBoost Price TargetHold$15.00 ➝ $20.00Low
i
7/6/2017JPMorgan Chase & Co.Reiterated RatingNeutral$10.00Low
i
Rating by Chris Schott at JPMorgan Chase & Co.
7/3/2017Wells Fargo & CompanyReiterated RatingUnderperformHigh
i
Rating by David Maris at Wells Fargo & Company
6/30/2017Stifel NicolausReiterated RatingBuy$35.00Low
i
6/28/2017Cantor FitzgeraldBoost Price TargetPositive$18.00 ➝ $23.00High
i
6/27/2017Wells Fargo & CompanyReiterated RatingSellN/A
i
Rating by David Maris at Wells Fargo & Company
6/20/2017MizuhoReiterated RatingUnderperform$8.00Medium
i
6/19/2017Royal Bank of CanadaSet Price TargetSector Perform$19.00Medium
i
Rating by Douglas Miehm at Royal Bank of Canada
6/17/2017GuggenheimInitiated CoverageBuy$18.00High
i
Rating by Louise Chen at Guggenheim
6/16/2017Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$18.00High
i
6/13/2017Royal Bank of CanadaReiterated RatingMarket Perform$19.00Medium
i
6/12/2017Wells Fargo & CompanyReiterated RatingUnderperformMedium
i
Rating by David Maris at Wells Fargo & Company
6/9/2017BMO Capital MarketsReiterated RatingMarket Perform$15.00Low
i
6/8/2017Canaccord GenuitySet Price TargetHold$12.00 ➝ $14.00High
i
Rating by Neil Maruoka at Canaccord Genuity
5/23/2017BarclaysReiterated RatingHold$20.00Low
i
5/19/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$18.00High
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
5/19/2017Wells Fargo & CompanyReiterated RatingSell$8.00Medium
i
Rating by David Maris at Wells Fargo & Company
5/19/2017Rodman & RenshawReiterated RatingNeutral$17.00Medium
i
5/17/2017Stifel NicolausReiterated RatingBuy$45.00 ➝ $35.00Low
i
5/10/2017HC WainwrightSet Price TargetHold$17.00Low
i
Rating by Ram Selvaraju at HC Wainwright
5/10/2017BMO Capital MarketsReiterated RatingMarket PerformHigh
i
5/10/2017ScotiabankBoost Price TargetSector Perform$12.00 ➝ $14.00High
i
5/10/2017TD SecuritiesLower Price TargetHold$18.50 ➝ $15.00High
i
5/10/2017BTIG ResearchReiterated RatingNeutralMedium
i
5/10/2017Stifel NicolausReiterated RatingBuy$45.00Medium
i
5/10/2017BarclaysReiterated RatingEqual Weight$20.00Medium
i
5/10/2017Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$18.00 ➝ $19.00High
i
5/9/2017JPMorgan Chase & Co.Reiterated RatingHoldMedium
i
Rating by Chris Schott at JPMorgan Chase & Co.
5/8/2017Canaccord GenuitySet Price TargetHold$12.00High
i
Rating by Neil Maruoka at Canaccord Genuity
5/6/2017Jefferies Financial GroupSet Price TargetBuy$18.00High
i
Rating by David Steinberg at Jefferies Financial Group Inc.
5/5/2017Wells Fargo & CompanyReiterated RatingUnderperformLow
i
Rating by David Maris at Wells Fargo & Company
5/4/2017Royal Bank of CanadaReiterated RatingSector Perform$18.00 ➝ $19.00High
i
4/26/2017ScotiabankLower Price TargetSector Perform$15.00 ➝ $12.00Low
i
4/23/2017Wells Fargo & CompanyReiterated RatingUnderperform$11.50 ➝ $8.00Medium
i
Rating by David Maris at Wells Fargo & Company
4/20/2017JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$15.00 ➝ $10.00Low
i
Rating by Chris Schott at JPMorgan Chase & Co.
4/19/2017Deutsche Bank AktiengesellschaftLower Price TargetHold$19.00 ➝ $18.00High
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
4/19/2017Royal Bank of CanadaReiterated RatingSector Perform$18.00High
i
4/17/2017MizuhoReiterated RatingUnderperform$9.00 ➝ $8.00Low
i
4/14/2017Piper Jaffray CompaniesReiterated RatingOutperform$10.00N/A
i
Rating by David Amsellem at Piper Jaffray Companies
3/23/2017Royal Bank of CanadaReiterated RatingSector Perform$21.00 ➝ $18.00Medium
i
3/14/2017Canaccord GenuitySet Price TargetHold$17.00 ➝ $12.00High
i
Rating by Neil Maruoka at Canaccord Genuity
3/14/2017Wells Fargo & CompanyReiterated RatingUnderperform$11.00 ➝ $10.00Medium
i
Rating by David Maris at Wells Fargo & Company
3/14/2017BMO Capital MarketsLower Price TargetMarket Perform$19.00 ➝ $15.00Medium
i
3/11/2017Morgan StanleyReiterated RatingEqual Weight$17.00 ➝ $12.00N/A
i
Rating by David Risinger at Morgan Stanley
3/7/2017Deutsche Bank AktiengesellschaftLower Price TargetHold$20.00 ➝ $19.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
3/6/2017HC WainwrightSet Price TargetHold$17.00N/A
i
Rating by Ram Selvaraju at HC Wainwright
3/6/2017MizuhoReiterated RatingUnderperformN/A
i
3/6/2017Wells Fargo & CompanyReiterated RatingUnderperform$11.50N/A
i
Rating by David Maris at Wells Fargo & Company
3/6/2017Rodman & RenshawLower Price TargetNeutral$23.00 ➝ $17.00N/A
i
3/3/2017BTIG ResearchReiterated RatingNeutralN/A
i
3/2/2017BMO Capital MarketsReiterated RatingMarket Perform$21.00 ➝ $19.00N/A
i
3/1/2017JPMorgan Chase & Co.Set Price TargetHold$15.00N/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
3/1/2017Jefferies Financial GroupLower Price TargetBuy$22.00 ➝ $18.00N/A
i
Rating by David Steinberg at Jefferies Financial Group Inc.
3/1/2017Royal Bank of CanadaLower Price Target$21.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
3/1/2017BMO Capital MarketsBoost Price Target$21.00N/A
i
2/28/2017GuggenheimReiterated RatingBuy$55.00N/A
i
Rating by Louise Chen at Guggenheim
2/28/2017HC WainwrightSet Price TargetHold$23.00N/A
i
Rating by Ram Selvaraju at HC Wainwright
2/28/2017Royal Bank of CanadaReiterated RatingSector Perform$22.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
2/27/2017Rodman & RenshawReiterated RatingNeutral$23.00 ➝ $17.00N/A
i
2/25/2017Wells Fargo & CompanySet Price TargetSell$11.00N/A
i
Rating by David Maris at Wells Fargo & Company
2/23/2017Wells Fargo & CompanyReiterated RatingUnderperform$11.50N/A
i
Rating by david maris at Wells Fargo & Company
2/22/2017Canaccord GenuitySet Price TargetHold$19.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
2/16/2017Wells Fargo & CompanyReiterated RatingUnderperformN/A
i
Rating by david maris at Wells Fargo & Company
2/16/2017MizuhoReiterated RatingUnderperform$11.00N/A
i
2/14/2017Royal Bank of CanadaLower Price TargetSector Perform$29.00 ➝ $22.00N/A
i
2/10/2017BarclaysLower Price TargetEqual Weight$34.00 ➝ $20.00N/A
i
2/9/2017BarclaysReiterated RatingHold$34.00N/A
i
2/9/2017Stifel NicolausReiterated RatingBuy$45.00N/A
i
2/7/2017GuggenheimReiterated RatingBuyN/A
i
Rating by Louise Chen at Guggenheim
1/31/2017Rodman & RenshawDowngradeBuy ➝ NeutralN/A
i
1/31/2017JPMorgan Chase & Co.Reiterated RatingNeutralN/A
i
1/21/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$24.00 ➝ $20.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
1/21/2017JPMorgan Chase & Co.Reiterated RatingNeutralN/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
1/12/2017Canaccord GenuityReiterated RatingHold$17.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
1/11/2017BTIG ResearchReiterated RatingNeutralN/A
i
1/11/2017Wells Fargo & CompanyReiterated RatingUnderperform$11.50N/A
i
Rating by david maris at Wells Fargo & Company
1/10/2017MizuhoReiterated RatingUnderperform$11.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
12/28/2016Deutsche Bank AktiengesellschaftReiterated RatingHold$24.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
12/15/2016Canaccord GenuityReiterated RatingHold$17.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
12/15/2016Wells Fargo & CompanyReiterated RatingUnderperformN/A
i
Rating by david maris at Wells Fargo & Company
12/15/2016Morgan StanleyDowngradeOverweight ➝ Equal Weight$25.00 ➝ $17.00N/A
i
Rating by David Risinger at Morgan Stanley
12/14/2016Piper Jaffray CompaniesSet Price TargetSell$16.00N/A
i
Rating by David Amsellem at Piper Jaffray Companies
12/9/2016MizuhoReiterated RatingPositiveN/A
i
Rating by Irina Rivkind Koffler at Mizuho
12/4/2016Canaccord GenuityReiterated RatingHold$17.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
12/1/2016Wells Fargo & CompanyReiterated RatingUnderperform$11.50N/A
i
Rating by david maris at Wells Fargo & Company
11/29/2016Deutsche Bank AktiengesellschaftSet Price TargetHold$24.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/23/2016MizuhoDowngradeNeutral ➝ Underperform$25.00 ➝ $11.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
11/20/2016Deutsche Bank AktiengesellschaftSet Price TargetHold$24.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/19/2016Canaccord GenuitySet Price TargetHold$17.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
11/18/2016Wells Fargo & CompanyReiterated RatingUnderperform$19.50 ➝ $11.50N/A
i
Rating by david maris at Wells Fargo & Company
11/14/2016Deutsche Bank AktiengesellschaftLower Price TargetHold$29.00 ➝ $24.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/10/2016ScotiabankReiterated RatingSector Perform$32.00 ➝ $17.00N/A
i
11/10/2016BarclaysReiterated RatingEqual Weight$34.00N/A
i
Rating by Douglas Tsao at Barclays PLC
11/10/2016Morgan StanleyLower Price TargetOverweight$42.00 ➝ $25.00N/A
i
Rating by David Risinger at Morgan Stanley
11/10/2016Wells Fargo & CompanyReiterated RatingUnderperform$19.50N/A
i
Rating by david maris at Wells Fargo & Company
11/10/2016MizuhoReiterated RatingNeutral$25.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
11/10/2016BMO Capital MarketsReiterated RatingMarket Perform$21.00 ➝ $29.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
11/10/2016Rodman & RenshawDowngradeBuy ➝ Neutral$81.00 ➝ $23.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
11/9/2016Jefferies Financial GroupReiterated RatingBuy$40.00 ➝ $22.00N/A
i
Rating by David Steinberg at Jefferies Financial Group Inc.
11/9/2016Canaccord GenuityReiterated RatingHold$33.00 ➝ $17.00N/A
i
Rating by neil maruoka at Canaccord Genuity
11/9/2016Royal Bank of CanadaSet Price TargetSector Perform$35.00 ➝ $29.00N/A
i
Rating by douglas miehm at Royal Bank of Canada
11/9/2016Royal Bank of CanadaLower Price TargetSector Perform$35.00 ➝ $29.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
11/8/2016Morgan StanleySet Price TargetBuy$42.00N/A
i
Rating by David Risinger at Morgan Stanley
11/8/2016GuggenheimReiterated RatingPositive$55.00N/A
i
11/3/2016Canaccord GenuityReiterated RatingHold$33.00N/A
i
Rating by neil maruoka at Canaccord Genuity
11/3/2016BTIG ResearchReiterated RatingNeutral$24.00N/A
i
11/2/2016Morgan StanleyReiterated RatingOverweight$42.00N/A
i
Rating by David Risinger at Morgan Stanley
11/1/2016ScotiabankReiterated RatingSector Perform$34.00 ➝ $32.00N/A
i
11/1/2016Wells Fargo & CompanyReiterated RatingUnderperformN/A
i
Rating by david maris at Wells Fargo & Company
11/1/2016MizuhoReiterated RatingNeutral$25.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
10/26/2016Wells Fargo & CompanyReiterated RatingUnderweight$19.50N/A
i
Rating by david maris at Wells Fargo & Company
10/25/2016JPMorgan Chase & Co.Reiterated RatingNeutralN/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
10/18/2016Wells Fargo & CompanyReiterated RatingUnderperform$19.50N/A
i
Rating by david maris at Wells Fargo & Company
10/14/2016Deutsche Bank AktiengesellschaftLower Price TargetHold$30.00 ➝ $29.00N/A
i
10/12/2016Royal Bank of CanadaReiterated RatingSector Perform$36.00 ➝ $47.50N/A
i
Rating by douglas miehm at Royal Bank of Canada
10/12/2016Royal Bank of CanadaLower Price TargetSector Perform$36.00 ➝ $35.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
9/30/2016Wells Fargo & CompanyReiterated RatingUnderperform$19.50N/A
i
Rating by david maris at Wells Fargo & Company
9/26/2016Royal Bank of CanadaReiterated RatingSector Perform$46.00N/A
i
Rating by douglas miehm at Royal Bank of Canada
9/20/2016Royal Bank of CanadaReiterated RatingSector PerformN/A
i
Rating by douglas miehm at Royal Bank of Canada
9/20/2016Deutsche Bank AktiengesellschaftInitiated CoverageHold$30.00N/A
i
9/18/2016Wells Fargo & CompanyReiterated RatingSell$19.50N/A
i
Rating by david maris at Wells Fargo & Company
9/7/2016Royal Bank of CanadaReiterated RatingSector Perform$36.00N/A
i
Rating by douglas miehm at Royal Bank of Canada
9/7/2016Morgan StanleyReiterated RatingOverweight$42.00N/A
i
Rating by David Risinger at Morgan Stanley
8/29/2016Royal Bank of CanadaReiterated RatingSector Perform$36.00N/A
i
Rating by douglas miehm at Royal Bank of Canada
8/26/2016Morgan StanleyReiterated RatingOverweight$42.00N/A
i
Rating by David Risinger at Morgan Stanley
8/22/2016Deutsche Bank AktiengesellschaftReiterated RatingPositiveN/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
8/19/2016Piper Jaffray CompaniesSet Price TargetSell$22.00N/A
i
Rating by David Amsellem at Piper Jaffray Companies
8/19/2016Royal Bank of CanadaSet Price TargetHold$36.00N/A
i
8/19/2016Canaccord GenuityReiterated RatingHold$31.00 ➝ $33.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
8/19/2016Morgan StanleyReiterated RatingPositiveN/A
i
Rating by David Risinger at Morgan Stanley
8/18/2016MizuhoReiterated RatingUnderperform$11.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
8/17/2016Morgan StanleyUpgradeEqual Weight ➝ Overweight$33.00 ➝ $42.00N/A
i
Rating by David Risinger at Morgan Stanley
8/16/2016Wells Fargo & CompanyReiterated RatingUnderperform$19.50N/A
i
Rating by David Maris at Wells Fargo & Company
8/15/2016MizuhoUpgradeUnderperform ➝ Neutral$25.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
8/13/2016TD SecuritiesReiterated RatingBuy$38.00N/A
i
Rating by Lennox Gibbs at TD Securities
8/11/2016MizuhoUpgradeUnderperform ➝ Neutral$25.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
8/11/2016GuggenheimReiterated RatingBuy$55.00N/A
i
Rating by Louise Chen at Guggenheim
8/11/2016Royal Bank of CanadaReiterated RatingSector Perform$31.00N/A
i
8/10/2016Wells Fargo & CompanyReiterated RatingUnderperform$19.50N/A
i
Rating by David Maris at Wells Fargo & Company
8/10/2016Canaccord GenuityReiterated RatingHold$28.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
8/10/2016BTIG ResearchReiterated RatingNeutralN/A
i
Rating by Tim Chiang at BTIG Research
8/10/2016Jefferies Financial GroupReiterated RatingBuy$40.00N/A
i
Rating by David Steinberg at Jefferies Financial Group Inc.
8/10/2016Piper Jaffray CompaniesBoost Price TargetUnderweight$19.00 ➝ $22.00N/A
i
Rating by David Amsellem at Piper Jaffray Companies
8/10/2016Royal Bank of CanadaBoost Price TargetSector Perform$31.00 ➝ $36.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
8/9/2016Rodman & RenshawLower Price TargetBuy$90.00 ➝ $81.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
8/3/2016Morgan StanleySet Price TargetHold$33.00N/A
i
Rating by David Risinger at Morgan Stanley
8/1/2016Canaccord GenuityReiterated RatingHold$28.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
8/1/2016Wells Fargo & CompanyReiterated RatingUnderperform$19.50N/A
i
Rating by David Maris at Wells Fargo & Company
7/28/2016Rodman & RenshawReiterated RatingBuy$90.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
7/26/2016ScotiabankReiterated RatingSector Perform$35.00 ➝ $32.00N/A
i
7/26/2016MizuhoReiterated RatingUnderperform$11.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
7/25/2016JPMorgan Chase & Co.Set Price TargetHold$35.00N/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
7/20/2016BMO Capital MarketsReiterated RatingMarket Perform$26.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
7/19/2016Royal Bank of CanadaReiterated RatingSector Perform$33.00N/A
i
7/18/2016Canaccord GenuityReiterated RatingHold$28.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
7/17/2016TD SecuritiesReiterated RatingHold$38.00N/A
i
Rating by Lennox Gibbs at TD Securities
7/17/2016MizuhoReiterated RatingUnderperformN/A
i
Rating by Irina Rivkind Koffler at Mizuho
7/17/2016Wells Fargo & CompanyReiterated RatingSell$19.50N/A
i
Rating by David Maris at Wells Fargo & Company
7/17/2016Rodman & RenshawReiterated RatingBuy$90.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
7/6/2016Rodman & RenshawReiterated RatingBuy$90.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
7/6/2016Stifel NicolausReiterated RatingBuy$55.00N/A
i
Rating by Annabel Samimy at Stifel Nicolaus
6/29/2016Wells Fargo & CompanyReiterated RatingSellN/A
i
Rating by David Maris at Wells Fargo & Company
6/28/2016BMO Capital MarketsInitiated CoverageMarket Perform$26.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
6/27/2016Royal Bank of CanadaReiterated RatingSector PerformN/A
i
Rating by Douglas Miehm at Royal Bank of Canada
6/22/2016JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Hold$50.00 ➝ $35.00N/A
i
Rating by Reiterated, Yesterday Hold at JPMorgan Chase & Co.
6/20/2016Wells Fargo & CompanyReiterated RatingSellN/A
i
Rating by David Maris at Wells Fargo & Company
6/16/2016Royal Bank of CanadaReiterated RatingHold$33.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
6/9/2016BTIG ResearchReiterated RatingNeutralN/A
i
Rating by Tim Chiang at BTIG Research
6/9/2016Royal Bank of CanadaLower Price TargetSector Perform$58.00 ➝ $33.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
6/8/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
6/8/2016GuggenheimReiterated RatingBuy$55.00N/A
i
Rating by Louise Chen at Guggenheim
6/8/2016BMO Capital MarketsReiterated RatingHold$44.00 ➝ $38.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
6/8/2016Jefferies Financial GroupReiterated RatingBuy$53.00 ➝ $40.00N/A
i
Rating by David Steinberg at Jefferies Financial Group Inc.
6/8/2016Stifel NicolausLower Price TargetBuy$65.00 ➝ $55.00N/A
i
Rating by Annabel Samimy at Stifel Nicolaus
6/7/2016Wells Fargo & CompanyReiterated RatingSell$27.50 ➝ $19.50N/A
i
Rating by David Maris at Wells Fargo & Company
6/7/2016MizuhoReiterated RatingSell$18.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
6/7/2016BarclaysReiterated RatingHold$34.00N/A
i
Rating by Douglas Tsao at Barclays PLC
6/7/2016Piper Jaffray CompaniesReiterated RatingSellN/A
i
Rating by David Amsellem at Piper Jaffray Companies
6/3/2016Canaccord GenuityReiterated RatingHold$40.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
6/3/2016Royal Bank of CanadaReiterated RatingSector Perform$58.00 ➝ $33.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
6/1/2016Morgan StanleyReiterated RatingHold$39.00N/A
i
Rating by David Risinger at Morgan Stanley
5/31/2016MizuhoReiterated RatingSellN/A
i
Rating by Irina Rivkind Koffler at Mizuho
5/29/2016Piper Jaffray CompaniesReiterated RatingSellN/A
i
Rating by David Amsellem at Piper Jaffray Companies
5/29/2016Susquehanna BancsharesReiterated RatingHold$105.00N/A
i
Rating by Andrew Finkelstein at Susquehanna Bancshares, Inc.
5/29/2016S&P Equity ResearchReiterated RatingBuyN/A
i
Rating by Jeffrey Loo at S&P Equity Research
5/27/2016BMO Capital MarketsReiterated RatingHold$44.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
5/27/2016Wells Fargo & CompanyReiterated RatingUnderperform$29.00 ➝ $27.50N/A
i
Rating by David Maris at Wells Fargo & Company
5/22/2016Royal Bank of CanadaReiterated RatingSector Perform$65.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
5/19/2016Wells Fargo & CompanyReiterated RatingUnderperform$30.50 ➝ $29.00N/A
i
Rating by David Maris at Wells Fargo & Company
5/9/2016Royal Bank of CanadaReiterated RatingSector Perform$65.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
5/5/2016BMO Capital MarketsReiterated RatingMarket Perform$66.00 ➝ $44.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
5/5/2016Piper Jaffray CompaniesReiterated RatingUnderweightN/A
i
Rating by David Amsellem at Piper Jaffray Companies
5/3/2016Rodman & RenshawLower Price TargetBuy$105.00 ➝ $102.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
4/29/2016BMO Capital MarketsReiterated RatingPositiveN/A
i
Rating by Alex Arfaei at BMO Capital Markets
4/28/2016MizuhoReiterated RatingUnderperform$18.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
4/27/2016Canaccord GenuityReiterated RatingHold$40.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
4/26/2016Royal Bank of CanadaReiterated RatingSector PerformN/A
i
Rating by Douglas Miehm at Royal Bank of Canada
4/26/2016Rodman & RenshawReiterated RatingBuy$105.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
4/25/2016Wells Fargo & CompanyReiterated RatingSellN/A
i
Rating by David Maris at Wells Fargo & Company
4/25/2016GuggenheimReiterated RatingBuy$55.00N/A
i
Rating by Louise Chen at Guggenheim
4/22/2016BMO Capital MarketsReiterated RatingBuy$66.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
4/18/2016Royal Bank of CanadaReiterated RatingSector Perform$65.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
4/18/2016MizuhoReiterated RatingUnderperformN/A
i
Rating by Irina Rivkind Koffler at Mizuho
4/15/2016Wells Fargo & CompanyReiterated RatingUnderperformN/A
i
Rating by David Maris at Wells Fargo & Company
4/13/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
4/11/2016Piper Jaffray CompaniesReiterated RatingSellN/A
i
Rating by David Amsellem at Piper Jaffray Companies
4/11/2016Stifel NicolausReiterated RatingBuy$65.00N/A
i
Rating by Annabel Samimy at Stifel Nicolaus
4/11/2016Royal Bank of CanadaReiterated RatingSector Perform$69.00 ➝ $65.00N/A
i
Rating by Douglas Miehm at Royal Bank of Canada
4/11/2016Rodman & RenshawLower Price TargetBuy$118.00 ➝ $105.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
4/9/2016Wells Fargo & CompanyReiterated RatingSellN/A
i
Rating by David Maris at Wells Fargo & Company
4/7/2016BTIG ResearchReiterated RatingNeutralN/A
i
Rating by Tim Chiang at BTIG Research
4/7/2016BMO Capital MarketsReiterated RatingMarket Perform$66.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
4/5/2016Canaccord GenuityReiterated RatingHoldN/A
i
Rating by Neil Maruoka at Canaccord Genuity
4/5/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Sahar Wolff at JPMorgan Chase & Co.
4/3/2016Rodman & RenshawReiterated RatingBuyN/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
4/1/2016CitigroupReiterated RatingBuyN/A
i
3/31/2016MizuhoReiterated RatingSellN/A
i
Rating by Irina Rivkind Koffler at Mizuho
3/28/2016Rodman & RenshawReiterated RatingBuy$118.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
3/28/2016Morgan StanleyReiterated RatingHold$39.00N/A
i
Rating by David Risinger at Morgan Stanley
3/25/2016BMO Capital MarketsReiterated RatingMarket Perform$66.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
3/22/2016Rodman & RenshawReiterated RatingBuyN/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
3/22/2016Nomura SecuritiesReiterated RatingNeutral$60.00N/A
i
Rating by Shibani Malhotra at Nomura Securities
3/21/2016UBS GroupReiterated RatingBuyN/A
i
Rating by Marc Goodman at UBS Group AG
3/21/2016BarclaysDowngradeOverweight ➝ Equal Weight$135.00 ➝ $34.00N/A
i
Rating by Douglas Tsao at Barclays PLC
3/21/2016MizuhoDowngradeNeutral ➝ UnderperformN/A
i
Rating by Irina Rivkind Koffler at Mizuho
3/19/2016GuggenheimReiterated RatingBuy$145.00 ➝ $55.00N/A
i
Rating by Louise Chen at Guggenheim
3/16/2016MizuhoDowngradeNeutral ➝ UnderperformN/A
i
Rating by Irina Rivkind Koffler at Mizuho
3/16/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
3/16/2016CitigroupReiterated RatingBuyN/A
i
3/16/2016S&P Equity ResearchReiterated RatingBuy$90.00 ➝ $30.00N/A
i
3/16/2016TD SecuritiesReiterated RatingHold$110.00 ➝ $45.00N/A
i
Rating by Lennox Gibbs at TD Securities
3/16/2016ScotiabankDowngradeOutperform ➝ Sector Perform$42.00N/A
i
Rating by A. Ridgeway at Scotiabank
3/16/2016Rodman & RenshawLower Price TargetBuy$150.00 ➝ $118.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
3/16/2016Nomura SecuritiesDowngradeBuy ➝ Neutral$175.00 ➝ $60.00N/A
i
Rating by Shibani Malhotra at Nomura Securities
3/16/2016Morgan StanleyLower Price TargetEqual Weight$98.00 ➝ $39.00N/A
i
Rating by David Risinger at Morgan Stanley
3/16/2016Royal Bank of CanadaLower Price TargetSector Perform$85.00 ➝ $69.00N/A
i
Rating by Downgraded, 2 days ago Hold at Royal Bank of Canada
3/15/2016BMO Capital MarketsReiterated RatingMarket Perform$133.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
3/15/2016JPMorgan Chase & Co.Lower Price TargetOverweight$200.00 ➝ $70.00N/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
3/15/2016Canaccord GenuityLower Price TargetHold$75.00 ➝ $40.00N/A
i
Rating by Neil Maruoka at Canaccord Genuity
3/15/2016UBS GroupReiterated RatingBuyN/A
i
Rating by Marc Goodman at UBS Group AG
3/15/2016Wells Fargo & CompanyReiterated RatingSellN/A
i
Rating by David Maris at Wells Fargo & Company
3/15/2016CIBCDowngradeSector Perform ➝ Sector Underperform$90.00 ➝ $24.00N/A
i
Rating by Stephanie Price at CIBC
3/15/2016Piper Jaffray CompaniesDowngradeNeutral ➝ UnderweightN/A
i
Rating by David Amsellem at Piper Jaffray Companies
3/14/2016Jefferies Financial GroupReiterated RatingBuy$106.00 ➝ $53.00N/A
i
Rating by David Steinberg at Jefferies Financial Group Inc.
3/12/2016GuggenheimReiterated RatingBuy$145.00N/A
i
Rating by Louise Chen at Guggenheim
3/12/2016Stifel NicolausReiterated RatingBuy$200.00 ➝ $65.00N/A
i
Rating by Adam Walsh at Stifel Nicolaus
3/8/2016MizuhoLower Price TargetNeutral$112.00 ➝ $70.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
(Data available from 3/7/2016 forward)
Bausch Health Companies logo
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Read More

Today's Range

Now: $32.97
$30.92
$33.11

50 Day Range

MA: $28.95
$24.79
$32.56

52 Week Range

Now: $32.97
$11.15
$33.11

Volume

4,145,167 shs

Average Volume

4,712,385 shs

Market Capitalization

$11.71 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Frequently Asked Questions

What sell-side analysts currently cover shares of Bausch Health Companies?

The following Wall Street analysts have issued research reports on Bausch Health Companies in the last year: Bank of America Co., Barclays PLC, Cfra, Citigroup Inc., HC Wainwright, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Royal Bank of Canada, SunTrust Banks, Inc., TheStreet, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for BHC.

What is the current price target for Bausch Health Companies?

12 Wall Street analysts have set twelve-month price targets for Bausch Health Companies in the last year. Their average twelve-month price target is $31.50, suggesting a possible downside of 4.5%. HC Wainwright has the highest price target set, predicting BHC will reach $50.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $17.00 for Bausch Health Companies in the next year.
View the latest price targets for BHC.

What is the current consensus analyst rating for Bausch Health Companies?

Bausch Health Companies currently has 5 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BHC will outperform the market and that investors should add to their positions of Bausch Health Companies.
View the latest ratings for BHC.

What other companies compete with Bausch Health Companies?

How do I contact Bausch Health Companies' investor relations team?

Bausch Health Companies' physical mailing address is 2150 ST. ELZEAR BLVD. WEST, LAVAL A8, H7L 4A8. The company's listed phone number is 514-744-6792 and its investor relations email address is [email protected] The official website for Bausch Health Companies is www.bauschhealth.com.